Department of Otorhinolaryngology and Head and Neck Surgery, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, I. P. Pavlova 6, 775 20, Olomouc, Czech Republic.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2022 Mar;166(1):46-50. doi: 10.5507/bp.2021.006. Epub 2021 Feb 4.
Endoscopic ear surgery (EES) is considered a minimally invasive technique. It is hypothesized that patients after endoscopic procedures experience less pain and require fewer painkillers. Our aim was to compare patients' postoperative pain and need for analgesics in patients undergoing microscopic and endoscopic ear surgeries.
a single-institution, prospective study included 92 patients undergoing ear procedures (48 cholesteatoma and 44 reconstructive);(43 endoscopic and 49 microscopic) during 1/2016-1/2018. The postoperative pain (visual analogue scale (VAS) 0-10) and painkillers consumption were recorded and compared in each subgroup.
VAS (P=0.02) and analgesics consumption (P=0.06) were lower after endoscopic ear surgeries. In the cholesteatoma group, 94% of endoscopic patients reported VAS 0-2 in contrast to 58 % of microscopic patients on day 1 (P=0.04). Similar tendencies were revealed in reconstructive cases, i.e. 92% compared to 73% (P>0.05). On day 1, 92% of endoscopic, and 77% of microscopic reconstruction patients received no painkillers group (P=0.06). In the cholesteatoma patients, 88% of endoscopic patients, 43% of microscopic patients using endaural approach, and 75% of microscopic patients using retroauricular approach, required no painkillers on the postoperative day 1 (P>0.05).
Our study revealed that the EES is associated with less postoperative pain than the conventional microscopic ear surgery. It seems that it is rather the transmeatal approach, and not the endoscope itself that reduces postoperative pain. The removal of the same size cholesteatoma using endoscope (rather than using microscope) leads to less intensive postoperative pain. Consequently, it was not surprising that patients after endoscopic ear surgery very rarely took painkillers.
内镜耳部手术(EES)被认为是一种微创技术。有假设认为,接受内镜手术的患者疼痛程度较低,需要的止痛药较少。我们的目的是比较接受显微镜和内镜耳部手术的患者术后疼痛和对止痛药的需求。
这是一项单中心前瞻性研究,纳入了 2016 年 1 月至 2018 年 1 月期间接受耳部手术(48 例胆脂瘤和 44 例重建手术)的 92 例患者(43 例内镜手术和 49 例显微镜手术)。记录并比较了每个亚组的术后疼痛(视觉模拟评分(VAS)0-10)和止痛药的使用情况。
EES 术后的 VAS(P=0.02)和止痛药的使用(P=0.06)较低。在胆脂瘤组中,94%的内镜患者在第 1 天报告 VAS 0-2,而 58%的显微镜患者报告 VAS 0-2(P=0.04)。在重建手术中也出现了类似的趋势,即 92%对比 73%(P>0.05)。在第 1 天,92%的内镜手术患者和 77%的显微镜手术患者无需服用止痛药(P=0.06)。在胆脂瘤患者中,88%的内镜患者、43%的经耳前入路的显微镜患者和 75%的经耳后入路的显微镜患者在术后第 1 天无需服用止痛药(P>0.05)。
我们的研究表明,EES 术后疼痛程度低于传统的显微镜耳部手术。似乎是经耳道入路而不是内镜本身减轻了术后疼痛。使用内镜(而不是显微镜)切除相同大小的胆脂瘤会导致术后疼痛程度较轻。因此,内镜耳部手术后患者很少需要止痛药就不足为奇了。